CBFs are often mutated in acute myeloid leukemia (AML), for example, in t(8;21) AMLs, characterized by expression of the AML1-ETO fusion gene, or inv(16) AMLs, delineated by the presence of the CBFβ-MYH11 (CM) event3. Here, RUNX1 is linked to acute myeloid leukemia.